Evotec and C4X Discovery upgrade joint research

Wednesday 28 September 2016
Country

United Kingdom

Evotec AG and C4X Discovery Holdings Plc have upgraded their research agreement to cover a broad range of targets for small molecule drugs. The initial focus will be on cancer and autoimmune diseases.